SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950116-04-001890
Filing Date
2004-06-14
Accepted
2004-06-14 17:22:37
Documents
4
Period of Report
2004-04-30

Document Format Files

Seq Description Document Type Size
1 10-Q tenq.txt 10-Q 144496
2 EXHIBIT 31.1 ex31-1.txt EX-31 3508
3 EXHIBIT 31.2 ex31-2.txt EX-31 3512
4 EXHIBIT 32 ex32.txt EX-32 1492
  Complete submission text file 0000950116-04-001890.txt   154843
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-25169 | Film No.: 04862296
SIC: 2834 Pharmaceutical Preparations